JamesBHermillerJr.MD

Cardiology • Indianapolis, IN

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Physician

Join to view full profile

Dr. Hermiller is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hermiller's full profile

Already have an account?

Office
10590 N Meridian St
Indianapolis, IN 46290
Phone+1 317-338-6666

Fax+1 317-338-6066

Education & Training

Duke University HospitalFellowship, Cardiovascular Disease, 1989 - 1992
National Capital ConsortiumResidency, Internal Medicine, 1983 - 1986
Ohio State University College of MedicineClass of 1983

Certifications & Licensure

IN State Medical License 1992 - 2025
NC State Medical License 1991 - 1998
MD State Medical License 1988 - 1990
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Clinical Trials

XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1) Start of enrollment: 2008 Jul 01
Completed
XIENCE V® USA Dual Antiplatelet Therapy (DAPT) Cohort Start of enrollment: 2009 Aug 01
Completed
Phase 4
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort) Start of enrollment: 2008 Jul 01
Completed
IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction Start of enrollment: 2012 Apr 01
Completed
Not Applicable
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Symptomatic Severe Aortic Stenosis in High Risk and Very High Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2010 Dec 10
Completed
Not Applicable
RESPECT Trial - (Rapid Extravascular Sealing Via PercutanEous Collagen ImplanT) Start of enrollment: 2011 Sep 01
Completed
Not Applicable
Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration Start of enrollment: 2012 Nov 13
Terminated
Phase 1, Phase 2
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI). Start of enrollment: 2012 Apr 01
Active, not recruiting
Not Applicable
A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System Start of enrollment: 2012 Dec 01
Terminated
Phase 3
Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement Start of enrollment: 2012 Aug 01
Active, not recruiting
Edwards EVOQUE Eos MISCEND Study Start of enrollment: 2015 Feb 06
Active, not recruiting
Not Applicable
WATCH-TAVR, WATCHMAN for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement Start of enrollment: 2017 Dec 15
Completed
Not Applicable
Portico NG Approval Study Start of enrollment: 2019 Sep 17
Active, not recruiting
Not Applicable
MitraClip REPAIR MR Study Start of enrollment: 2020 Jul 21
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

390 citations
Transcatheter aortic-valve replacement with a self-expanding prosthesis.
David H Adams, Jeffrey J Popma, Michael J Reardon, Steven J Yakubov, Joseph S Coselli
The New England Journal of Medicine. 2014-05-08
245 citations
5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients
Thomas G. Gleason, Michael J. Reardon, Jeffrey J. Popma, G. Michael Deeb, Steven J. Yakubov
Journal of the American College of Cardiology. 2018-12-04
31 citations
Percutaneous Atriotomy for Levoatrial-to-Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience.
Trevor Simard, Marino Labinaz, Firas Zahr, Babak Nazer, William A. Gray
JACC. Cardiovascular Interventions. 2020-05-25

Lectures

AMULET: Device Characteristics, Procedural Technique, Clinical Outcomes, and Ongoing Studies
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
An Optimized, Upfront Two-Stent Strategy (a.k.a. DK Crush) Is My New Standard!
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
TCT 77: Transcarotid Versus Subclavian/Axillary Access for Transcatheter Aortic Valve Replacement: Real World Comparative Outcomes Utilizing the TVT Registry
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019
Delivering Evidence
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
The Growing Concern of Coronary Access After TAVR: Procedural Problem-Solving and Impact on TAVR Device Choices
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/26/2019
Interventional Live Case Session IV: Coronary Transmission from University of Washington Medical Center
2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
2012 Scientific Sessions of the Society for Cardiovascular Angiography & Interventions (SCAI)
Society for Cardiovascular Angiography and Interventions, Las Vegas, Nevada - 5/9/2012
Join now to see all

Press Mentions

‘Hot’ Doc? Radiation Exposure Risks of Interventionalists Aired in TV SpecialSeptember 25th, 2024
PAD Is a Public Health Crisis Say Cardiovascular SocietiesSeptember 9th, 2024
Encouraging 3-Year Data for TAVR in Low-Risk Patients: EVOLUTMarch 8th, 2023
Join now to see all

Professional Memberships

American College of Cardiology - ACC
Fellow